Featured Research

from universities, journals, and other organizations

Using A Patient’s Own Bone Marrow Cells Can Help An Ailing Heart

Date:
November 14, 2001
Source:
American Heart Association
Summary:
In the first study of its kind, researchers have used a person’s own bone marrow cells to improve blood flow in otherwise untreatable coronary arteries, according to research presented today at the American Heart Association’s Scientific Sessions 2001 conference.

ANAHEIM, Calif., Nov. 12 – In the first study of its kind, researchers have used a person’s own bone marrow cells to improve blood flow in otherwise untreatable coronary arteries, according to research presented today at the American Heart Association’s Scientific Sessions 2001 conference.

Kimikazu Hamano, M.D., and his colleagues reported results from an ongoing clinical trial in which five patients received injections of their own bone marrow cells into oxygen-starved areas of their hearts. Three of these patients later had increased blood flow in these areas. "We found this new treatment to be safe, and we believe it could be an alternative treatment for heart patients who cannot be helped by coronary artery bypass surgery or balloon angioplasty," says Hamano, a lecturer at the Yamaguchi University School of Medicine in Ube, Japan. Bypass surgery and angioplasty can improve blood flow to the hearts of many patients whose coronary arteries are clogged and narrowed by fatty deposits. But others cannot be helped at all or portions of their heart cannot benefit from the procedures. This is often because their heart disease is too widespread.

Injecting adult stem cells from the patient’s own bone marrow is easy, relatively inexpensive and appears to have no side effects, Hamano says. Stem cells are basic building block cells that can grow into specialized cells in the body, such as heart cells, nerve cells and organ cells. The Japanese team began their human trial after a series of animal experiments. The first patient was injected with his own bone marrow cells in November 1999.

"We have good results from these experiments in animal studies," Hamano says. "The aim of the current trial is to confirm the safety and efficacy of this treatment in humans." He and his colleagues selected their study participants from among patients who were scheduled to undergo bypass surgery. Their five patients had an average age of 66 and all suffered severe and debilitating chest pain (angina). They were chosen because areas of their heart muscle could not receive any benefit from the bypass surgery.

As surgeons began bypass surgery on each participant, the researchers withdrew bone marrow from the patient’s hip bone. From this harvested marrow, they prepared a mixture rich in mononuclear cells, which includes immature cells such as stem cells and the precursor cells of the endothelial cells that line the inner walls of blood vessels.

Depending on the size of the area of heart muscle treated, the patients received between five and 22 injections of cells into the heart muscle, administered 1 centimeter (0.39 inch) apart. The patients were examined one month after their injections/operations using a nuclear medicine test called cardiac scintigraphy. Scintigraphy measures coronary perfusion, which is the amount of blood flowing to the heart. All of the patients have been followed for at least one year.

Three of the five patients showed marked improvement in blood flow to the parts of their heart treated with bone marrow. Their severe chest pain also had disappeared. The other two patients, however, had no change in blood flow compared to preoperative tests. Chest X-rays, blood tests, electrocardiography, and ultrasound studies did not reveal any detrimental changes in any patients.

Despite evidence in three patients of increased blood flow in the treated areas, “It was difficult to clearly identify new vessels formed by this treatment on postoperative angiograms,” Hamano says. Angiography uses a combination of X-rays and a dye injected into the heart’s arteries to visualize the organ’s blood vessels. However, this failure to detect new vessels did not surprise the researchers.

"From our experimental data, the new vessels formed as the result of bone marrow cell injections were only 30 to 60 micrometers (about 0.00117 to 0.00234 inch) in diameter," Hamano explains. "The detection level of blood vessels by angiography is more than 200 micrometers. Therefore, it is understandable that we could not see the new vessels."

The important finding, he says, is the evidence of greater blood flow to the heart muscle. Hamano and his colleagues have now treated a sixth patient as part of their continuing study. Co-authors are: Masahiko Nishida, M.D.; Ken Hirata, M.D.; Akihito Mikamo, M.D., Ph.D.; Tao-Sheng Li, M.D., Ph.D.; Kensuke Esato, M.D., Ph.D.; Masahiko Harada, M.D., Ph.D.; and Toshiro Miura, M.D., Ph.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Using A Patient’s Own Bone Marrow Cells Can Help An Ailing Heart." ScienceDaily. ScienceDaily, 14 November 2001. <www.sciencedaily.com/releases/2001/11/011114071845.htm>.
American Heart Association. (2001, November 14). Using A Patient’s Own Bone Marrow Cells Can Help An Ailing Heart. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2001/11/011114071845.htm
American Heart Association. "Using A Patient’s Own Bone Marrow Cells Can Help An Ailing Heart." ScienceDaily. www.sciencedaily.com/releases/2001/11/011114071845.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins